Endonovo Therapeutics, Inc. SEC filings ENDV
Endonovo Therapeutics, Inc. has 502 filings in SEC EDGAR's recent list, going back to Sep 22, 2011. Its latest annual report, Form 10-K, was filed on Apr 17, 2023 for the period ended Dec 31, 2022. The latest quarterly report (Form 10-Q) was filed on Dec 29, 2023, covering the quarter ended Sep 30, 2023. The most recent current report (Form 8-K) was filed on Jan 3, 2024 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SEC STAFF ACTION | Filing | Sep 19, 2024 | — |
| 15-12G | Deregistration | Feb 2, 2024 | — |
| NT 10-Q | Filing | Nov 15, 2023 | Sep 30, 2023 |
| 1-A/A | Filing | Aug 25, 2023 | — |
| NT 10-Q | Filing | Aug 15, 2023 | Jun 30, 2023 |
| 1-A/A | Filing | Jun 14, 2023 | — |
| NT 10-Q | Filing | May 16, 2023 | Mar 31, 2023 |
| NT 10-K | Filing | Mar 31, 2023 | Dec 31, 2022 |
| NT 10-Q | Filing | Nov 14, 2022 | Sep 30, 2022 |
| NT 10-Q | Filing | Aug 15, 2022 | Jun 30, 2022 |
| NT 10-Q | Filing | May 16, 2022 | Mar 31, 2022 |
| 1-A/A | Filing | May 10, 2022 | — |
| NT 10-K | Filing | Mar 31, 2022 | Dec 31, 2021 |
| 1-A | Filing | Feb 11, 2022 | — |
| NT 10-Q | Filing | Nov 15, 2021 | Sep 30, 2021 |
| NT 10-Q | Filing | Aug 16, 2021 | Jun 30, 2021 |
| NT 10-Q | Filing | May 17, 2021 | Mar 31, 2021 |
| NT 10-K | Filing | Mar 31, 2021 | Dec 31, 2020 |
| NT 10-Q | Filing | Nov 16, 2020 | Sep 30, 2020 |
| NT 10-Q | Filing | Aug 11, 2020 | Jun 30, 2020 |
| EFFECT | Filing | Jul 16, 2020 | — |
| CORRESP | Letter to the SEC | Jul 13, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 30, 2020 | — |
| EFFECT | Filing | Jun 8, 2020 | — |
| RW WD | Filing | Jun 2, 2020 | — |
| RW | Filing | May 29, 2020 | — |
| NT 10-Q | Filing | May 14, 2020 | Mar 31, 2020 |
| NT 10-K | Filing | Mar 26, 2020 | Dec 31, 2019 |
| D | Filing | Nov 22, 2019 | — |
| NT 10-Q | Filing | Nov 14, 2019 | Sep 30, 2019 |
| NT 10-K | Filing | Mar 29, 2019 | Dec 31, 2018 |
| EFFECT | Filing | Feb 11, 2019 | — |
| UPLOAD | Letter from the SEC | Feb 8, 2019 | — |
| CORRESP | Letter to the SEC | Feb 6, 2019 | — |
| NT 10-Q | Filing | May 16, 2018 | Mar 31, 2018 |
| NT 10-K | Filing | Apr 3, 2018 | Dec 31, 2017 |
| D | Filing | Dec 29, 2017 | — |
| NT 10-K | Filing | Apr 3, 2017 | Dec 31, 2016 |
| UPLOAD | Letter from the SEC | Jan 11, 2017 | — |
| EFFECT | Filing | Oct 17, 2016 | — |
| CORRESP | Letter to the SEC | Oct 14, 2016 | — |
| CORRESP | Letter to the SEC | Oct 6, 2016 | — |
| UPLOAD | Letter from the SEC | Sep 23, 2016 | — |
| NT 10-Q | Endv nt 10-q 03/31/16 | May 16, 2016 | Mar 31, 2016 |
| NT 10-K | Endv nt 10-k 12/31/15 | Mar 31, 2016 | Dec 31, 2015 |
| EFFECT | Filing | Mar 14, 2016 | — |
| D | Filing | Feb 19, 2016 | — |
| NT 10-Q | Endv nt 10-q 09/30/15 | Nov 16, 2015 | Sep 30, 2015 |
| NT 10-Q | Endv nt 10-q 06/30/15 | Aug 14, 2015 | Jun 30, 2015 |
| 8-A12G | For registration of certain classes | Jun 15, 2015 | — |
| NT 10-Q | Endv nt 10-q 03/31/15 | May 15, 2015 | Mar 31, 2015 |
| EFFECT | Filing | May 1, 2015 | — |
| RW | Endv rw 04/30/15 | May 1, 2015 | — |
| EFFECT | Filing | Apr 30, 2015 | — |
| CORRESP | Letter to the SEC | Apr 27, 2015 | — |
| NT 10-K | Endv nt 10-k 12/31/14 | Mar 30, 2015 | Dec 31, 2014 |
| UPLOAD | Letter from the SEC | Feb 19, 2015 | — |
| D | Filing | Dec 9, 2014 | — |
| D | Filing | Dec 3, 2014 | — |
| D/A | Filing | Dec 3, 2014 | — |
| D | Filing | Sep 5, 2014 | — |
| NT 10-Q | Endo nt 10-q 06/30/14 | Aug 14, 2014 | Jun 30, 2014 |
| D/A | Filing | Aug 11, 2014 | — |
| NT 10-K | Endo nt 10-k 12/31/13 | Mar 31, 2014 | Dec 31, 2013 |
| D | Filing | Nov 15, 2013 | — |
| NT 10-Q | Hvpa nt 10-q 09/30/13 | Nov 14, 2013 | Sep 30, 2013 |
| NT 10-Q | Hvpa nt 10-q 06/30/13 | Aug 14, 2013 | Jun 30, 2013 |
| NT 10-Q | Hvpa nt 10-q 03/31/13 | May 16, 2013 | Mar 31, 2013 |
| NT 10-K | Hpai nt 10-k 12/31/12 | Apr 1, 2013 | Dec 31, 2012 |
| NT 10-Q/A | Hpa nt 10-q 09/30/12 | Nov 21, 2012 | Sep 30, 2012 |
| NT 10-Q | Hanover nt10-q 09/30/12 | Nov 15, 2012 | Sep 30, 2012 |
| NT 10-Q | Hanover nt 10-q 06/30/12 | Aug 14, 2012 | Jun 30, 2012 |
| NT 10-Q | Hanover nt 10-q 03/31/12 | May 15, 2012 | Mar 31, 2012 |
| NT 10-K | Hpa nt 10-k 12/31/11 | Mar 30, 2012 | Dec 31, 2011 |
| EFFECT | Filing | Dec 7, 2011 | — |
| CORRESP | Letter to the SEC | Dec 5, 2011 | — |
| CORRESP | Letter to the SEC | Nov 29, 2011 | — |
| UPLOAD | Letter from the SEC | Nov 23, 2011 | — |
| CORRESP | Letter to the SEC | Nov 14, 2011 | — |
| UPLOAD | Letter from the SEC | Oct 17, 2011 | — |
Showing 80 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- ENDV (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Woodland Hills, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1528172
- Former names
- Hanover Portfolio Acquisitions, Inc. (until Jan 24, 2014)
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
All 31 Electromedical & Electrotherapeutic Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.